Sign inGet started

Canaan Management, Inc.

Insider CIK 1555070 · DRTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DRTX Durata Therapeutics, Inc. D To issuer deriv2014-11-172014-11-198,575— $00SEC↗
DRTX Durata Therapeutics, Inc. D To issuer deriv2014-11-172014-11-191,216— $00SEC↗
DRTX Durata Therapeutics, Inc. U Tender2014-11-172014-11-191,902,030— $00SEC↗
DRTX Durata Therapeutics, Inc. D To issuer2014-11-172014-11-195,034— $00SEC↗
DRTX Durata Therapeutics, Inc. M Exercise deriv2014-08-262014-11-196,250— $00SEC↗
DRTX Durata Therapeutics, Inc. M Exercise deriv2014-08-262014-11-191,216— $01,216SEC↗
DRTX Durata Therapeutics, Inc. M Exercise2014-08-262014-11-195,034$2.08 $10.5K5,034SEC↗
DRTX Durata Therapeutics, Inc. A Award deriv2014-05-212014-05-238,575— $014,825SEC↗
DRTX Durata Therapeutics, Inc. C Conversion deriv2012-07-242012-07-2710,771,804— $00SEC↗
DRTX Durata Therapeutics, Inc. C Conversion2012-07-242012-07-271,346,475— $01,346,475SEC↗
DRTX Durata Therapeutics, Inc. P Buy2012-07-242012-07-27555,555$9.00 $5.00M1,902,030SEC↗
DRTX Durata Therapeutics, Inc. A Award deriv2012-02-282012-07-276,250— $06,250SEC↗